EU countries join forces to ensure people have access to a COVID-19 vaccine

02 July 2020

Last week, the EU countries and the European Commission published a European strategy to ensure citizens have swift access to a safe and effective COVID-19 vaccine. The Danish Medicines Agency participates as representative of Denmark in a European steering board that will be coordinating the joint procurement of vaccines.

COVID-19 has already cost thousands of human lives in Europe with significant human suffering and economic costs. One of the important elements in the fight against COVID-19 is to ensure people have access to a vaccine once it has been developed, and Denmark is working together with the rest of the EU member states within the scope of a common strategy with the following objectives:

  • Ensuring the quality, safety and efficacy of vaccines,
  • Securing swift access to vaccines for all Danes and other EU nationals, and
  • Ensuring equitable access to an affordable vaccine as early as possible.

Vaccine development is a complex and lengthy process that normally takes more than 10 years. However, as part of the joint action of all countries in the EU, the aim is to develop a vaccine within a timeframe of 12 to 18 months or earlier.

Securing a fair access to the vaccines

In order to support the pharmaceutical companies in the swift development and large-scale production of a vaccine, the European countries will jointly enter into agreements with individual vaccine manufacturers under which the EU will finance part of the costs associated with the development of a vaccine.

In return for this, the EU will have the right to buy a specified number of vaccine doses in a given timeframe through an advance agreement. This means that the funding provided will be considered as a down-payment on the vaccines that will actually be purchased by the member states. At the same time, the initiative will pool the resources of the EU countries to secure a fair access to the vaccines for everyone in the EU – including in lower-income countries.

The Danish Medicines Agency represents Denmark in a European steering board that will be coordinating the joint procurement of vaccines.

Read more:

EU's vaccine strategy

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.


...